Discern

Project Description

DISCERN aims to uncover novel causes of renal, pancreatic, and colorectal cancers.

The project will incorporate large-scale cancer biorepositories and novel exposomics techniques to understand the causes of these three poorly understood cancer types in Europe.
It also aims to explain their geographical distribution, including their high incidence in central and eastern Europe.
It will integrate large-scale cancer biorepositories and state-of-the-art exposomics and proteomics techniques, as well as genomics technologies, to compare normal tissue with tumour tissue.

The comparison will unravel novel causes for each of these three cancers to ultimately provide scientific evidence necessary to develop new prevention strategies for these cancers in Europe.

To find out more about the project, please visit the official website of DISCERN

Disclaimer: Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.

EU

Funded by
the European Union

DISCERN is funded by the European Union (grant number 101096888)

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.